U.S. Markets close in 6 hrs 1 min
  • S&P 500

    3,787.37
    -62.25 (-1.62%)
     
  • Dow 30

    30,455.74
    -481.30 (-1.56%)
     
  • Nasdaq

    13,403.83
    -222.23 (-1.63%)
     
  • Russell 2000

    2,092.82
    -57.03 (-2.65%)
     
  • Crude Oil

    52.05
    -0.56 (-1.06%)
     
  • Gold

    1,832.20
    -18.70 (-1.01%)
     
  • Silver

    24.81
    -0.73 (-2.85%)
     
  • EUR/USD

    1.2080
    -0.0065 (-0.5315%)
     
  • 10-Yr Bond

    1.0040
    -0.0360 (-3.46%)
     
  • Vix

    28.37
    +5.35 (+23.24%)
     
  • GBP/USD

    1.3687
    +0.0012 (+0.0849%)
     
  • USD/JPY

    104.0580
    +0.3020 (+0.2911%)
     
  • BTC-USD

    29,449.34
    -2,399.08 (-7.53%)
     
  • CMC Crypto 200

    593.59
    -46.33 (-7.24%)
     
  • FTSE 100

    6,521.82
    -132.19 (-1.99%)
     
  • Nikkei 225

    28,635.21
    +89.01 (+0.31%)
     

$489.2 Million Worldwide Helicobacter Pylori Diagnostics Industry to 2027 - Impact of COVID-19 on the Market - ResearchAndMarkets.com

·2 min read

The "Helicobacter Pylori Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

The publisher brings years of research experience to the 5th edition of this report. The 278-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Global Helicobacter Pylori Diagnostics Market to Reach $729.2 Million by 2027

Amid the COVID-19 crisis, the global market for Helicobacter Pylori Diagnostics estimated at US$489.2 Million in the year 2020, is projected to reach a revised size of US$729.2 Million by 2027, growing at a CAGR of 5.9% over the period 2020-2027.

Invasive, one of the segments analyzed in the report, is projected to record 5.4% CAGR and reach US$341.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Invasive segment is readjusted to a revised 6.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $132.5 Million, While China is Forecast to Grow at 8.9% CAGR

The Helicobacter Pylori Diagnostics market in the U.S. is estimated at US$132.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$153.3 Million by the year 2027 trailing a CAGR of 8.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Competitors identified in this market include, among others:

  • Abbott Laboratories

  • Bio-Rad Laboratories, Inc.

  • Cardinal Health, Inc.

  • DiaSorin SpA

  • Exalenz Bioscience Ltd.

  • F. Hoffmann-La Roche AG

  • Halyard Health, Inc.

  • Meridian Bioscience, Inc.

  • Quidel Corporation

  • Thermo Fisher Scientific, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares

  • Helicobacter Pylori Diagnostics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 44

For more information about this report visit https://www.researchandmarkets.com/r/8vz1am

View source version on businesswire.com: https://www.businesswire.com/news/home/20201229005350/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900